First Time Loading...

Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.16 CAD Market Closed
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.82 CAD with a low forecast of 0.81 CAD and a high forecast of 0.84 CAD.

TLT Lowest Forecast
Wall Street Target
0.81 CAD
405% Upside
TLT Average Forecast
Wall Street Target
0.82 CAD
410% Upside
TLT Highest Forecast
Wall Street Target
0.84 CAD
425% Upside
Lowest
Price Target
0.81 CAD
405% Upside
Average
Price Target
0.82 CAD
410% Upside
Highest
Price Target
0.84 CAD
425% Upside
Theralase Technologies Inc Competitors:
Price Targets
6669
Acotec Scientific Holdings Ltd
150% Upside
PRN
Profound Medical Corp
63% Upside
EKTA B
Elekta AB (publ)
8% Upside
D
7775
Daiken Medical Co Ltd
62% Upside
6669
Acotec Scientific Holdings Ltd
150% Upside
PRN
Profound Medical Corp
63% Upside
EKTA B
Elekta AB (publ)
8% Upside
D
7775
Daiken Medical Co Ltd
62% Upside
AXNX
Axonics Inc
9% Upside
TFX
Teleflex Inc
34% Upside
ZBH
Zimmer Biomet Holdings Inc
16% Upside
CYRX
Cryoport Inc
17% Upside

Revenue
Forecast

Revenue Estimate
Theralase Technologies Inc

For the last 8 years the compound annual growth rate for Theralase Technologies Inc's revenue is -7%. The projected CAGR for the next 3 years is 222%.

-7%
Past Growth
222%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Theralase Technologies Inc

Operating Income forecast
is not available for
Theralase Technologies Inc

Net Income
Forecast

Net Income Estimate
Theralase Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
What are analyst estimates?

See Also

Summary
TLT intrinsic value, competitors valuation, and company profile.
DCF Valuation
TLT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TLT stock valuation using valuation multiples.
Wall Street Estimates
TLT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TLT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLT's stock price target?
Price Target
0.82 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.82 CAD with a low forecast of 0.81 CAD and a high forecast of 0.84 CAD.

What is Theralase Technologies Inc's Revenue forecast?
Projected CAGR
222%

For the last 8 years the compound annual growth rate for Theralase Technologies Inc's revenue is -7%. The projected CAGR for the next 3 years is 222%.

ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.